ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023
2D Organic Materials: Status and Challenges.
Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Isosteric Substitution Enables Rational Design of Two-Dimensional Energetic Crystals.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Computational Mechanics Model to Evaluate the Structural Maintenance of Catenated Hydrogen-Bonded Organic Frameworks.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Pore engineering in metal-organic frameworks and covalent organic frameworks: strategies and applications.Chemical science · 2025Review
- A review of combined imaging and therapeutic applications based on MNMs.Frontiers in chemistry · 2025Review
- Article
- Solution-Processed Monolayer Molecular Crystals: From Precise Preparation to Advanced Applications.Precision chemistry · 2024Review
- Transition Metal-Based Dimeric Metallosurfactants: From Organic-Inorganic Hybrid Structures and Low-Dimensional Magnets to Metallomicelles.Inorganic chemistry · 2024Article
- 2-(10-Bromo-anthracen-9-yl)-IUCrData · 2024Article
- 9,10-Bis(iodo-ethyn-yl)anthracene.IUCrData · 2023Article
- 2D Organic Materials: Status and Challenges.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
In the past few decades, 2D layer materials have gradually become a central focus in materials science owing to their uniquely layered structural qualities and good optoelectronic properties. However, in the development of 2D materials, several disadvantages, such as limited types of materials and the inability to synthesize large-scale materials, severely confine their application. Therefore, further exploration of new materials and preparation methods is necessary to meet technological developmental needs. Organic molecular materials have the advantage of being customizable. Therefore, if organic molecular and 2D materials are combined, the resulting 2D organic materials would have excellent optical and electrical properties. In addition, through this combination, the free design and large-scale synthesis of 2D materials can be realized in principle. Furthermore, 2D organic materials exhibit excellent properties and unique functionalities along with great potential for developing sensors, biomedicine, and electronics. In this review, 2D organic materials are divided into five categories. The preparation methods and material properties of each class of materials are also described in detail. Notably, to comprehensively understand each material's advantages, the latest research applications for each material are presented in detail and summarized. Finally, the future development and application prospects of 2D organic materials are briefly discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.